1. Home
  2. FFWM vs PCRX Comparison

FFWM vs PCRX Comparison

Compare FFWM & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FFWM
  • PCRX
  • Stock Information
  • Founded
  • FFWM 1990
  • PCRX 2006
  • Country
  • FFWM United States
  • PCRX United States
  • Employees
  • FFWM N/A
  • PCRX N/A
  • Industry
  • FFWM Major Banks
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FFWM Finance
  • PCRX Health Care
  • Exchange
  • FFWM Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • FFWM 510.5M
  • PCRX 604.7M
  • IPO Year
  • FFWM 2014
  • PCRX 2011
  • Fundamental
  • Price
  • FFWM $6.25
  • PCRX $22.36
  • Analyst Decision
  • FFWM Buy
  • PCRX Buy
  • Analyst Count
  • FFWM 4
  • PCRX 10
  • Target Price
  • FFWM $6.75
  • PCRX $27.60
  • AVG Volume (30 Days)
  • FFWM 513.3K
  • PCRX 810.1K
  • Earning Date
  • FFWM 01-30-2025
  • PCRX 02-27-2025
  • Dividend Yield
  • FFWM 0.32%
  • PCRX N/A
  • EPS Growth
  • FFWM N/A
  • PCRX N/A
  • EPS
  • FFWM N/A
  • PCRX N/A
  • Revenue
  • FFWM $108,182,000.00
  • PCRX $694,957,000.00
  • Revenue This Year
  • FFWM N/A
  • PCRX $4.83
  • Revenue Next Year
  • FFWM $31.36
  • PCRX $2.16
  • P/E Ratio
  • FFWM N/A
  • PCRX N/A
  • Revenue Growth
  • FFWM N/A
  • PCRX 4.40
  • 52 Week Low
  • FFWM $4.84
  • PCRX $11.16
  • 52 Week High
  • FFWM $11.47
  • PCRX $34.01
  • Technical
  • Relative Strength Index (RSI)
  • FFWM 46.63
  • PCRX 70.92
  • Support Level
  • FFWM $6.00
  • PCRX $18.18
  • Resistance Level
  • FFWM $6.38
  • PCRX $22.36
  • Average True Range (ATR)
  • FFWM 0.28
  • PCRX 1.13
  • MACD
  • FFWM 0.07
  • PCRX 0.30
  • Stochastic Oscillator
  • FFWM 80.23
  • PCRX 93.11

About FFWM First Foundation Inc.

First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

Share on Social Networks: